Skip to main content

Micro-Physiological Systems for Efficacy and Safety Studies: A Workshop on Advances in Organs-On-Chip Technologies for Animals

Completed

Any project, supported or not by a committee, that has not deposited records to the Records Office.

Microphysiological systems (MPS) are in vitro platforms composed of 3-D constructs (including spheroids, organoids, bioprinted, and tissue/organs-on-chips) of human or animal origin in micro-bioreactors that mimic the biochemical, electrical, mechanical properties of organ or tissue function. MPS are predictive tools enabling more physiologically meaningful pharmacology, toxicology and efficacy assessments in drug development. Workshop will discuss current MPS landscape, particularly in developing animal organs-on-chips and establishment of sustainable animal chip banks for large-scale use. MPS will be explored for a range of animal species/strains, including pathogen-free and gene-edited animals, and for optimizing animal model selection where whole animal models are necessary.

Description

The National Academies of Sciences, Engineering, and Medicine will appoint a planning committee to organize and convene a workshop on advances in micro-physiological systems (MPS). The purpose of the workshop is to promote discussion and understanding of progress made toward developing more physiologically realistic organs-on-chips (OOCs), particularly with regard to developing animal OOCs and sustainable animal chip banks. Presentations and discussions may explore the following topics and questions:

· What do emerging MPS or OOC technologies enable researchers to achieve that could not be achieved before these artificial biological platforms were developed? Which applications are currently most robust and reproducible?

· How can emerging OOCs or system biology technologies enable researchers to improve in vitro techniques as an alternative to using animal models?

· What are the current strategic goals to advance or improve upon these technologies, particularly as they pertain to reduction of the use of whole live animal models?

· What are the major technological hurdles or knowledge gaps to overcome in order to realize impacts on drug safety testing?

· What are the challenges and opportunities associated with educating and training traditional research scientists to use OOCs?

· What are the determining factors for translating the technologies used for human OOCs to animal OOCs and for creating sustainable animal chip banks?

The workshop presentations and discussions will be documented in a workshop proceedings authored by rapporteur(s) in accordance with National Academies guidelines.


Collaborators

Committee

Co-Chair

Co-Chair

Member

Member

Member

Member

Member

Member

Member

Sponsors

Department of Veterans Affairs

Environmental Protection Agency

National Center for Advancing Translational Sciences

U.S. Department of Agriculture - Animal and Plant Health Inspection Service

U.S. Food and Drug Administration

Staff

Teresa Sylvina

Lead

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.